We are live on ! Find out more
IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

48 hedge funds and large institutions have $44.4M invested in iShares Genomics Immunology and Healthcare ETF in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 11

1.63% more ownership

Funds ownership: 39.23% → 40.86% (+1.6%)

9% less capital invested

Capital invested by funds: $48.8M → $44.4M (-$4.46M)

17% less funds holding

Funds holding: 58 → 48 (-10)

67% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 15

Holders
48
Holders Change
-10
Holders Change %
-17.24%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
17
Reduced
11
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Raymond James Financial
Raymond James Financial
Florida
+$2.16M
2
UBS Group
UBS Group
Switzerland
+$1.68M
3
Bank of America
Bank of America
North Carolina
+$1.43M
4
Morgan Stanley
Morgan Stanley
New York
+$363K
5
WBG
Wharton Business Group
Pennsylvania
+$332K

Top Sellers

Rank Fund Capital Flow
1
FTUS
Flow Traders U.S.
New York
-$2.13M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.26M
3
TW
Transform Wealth
Colorado
-$721K
4
Jane Street
Jane Street
New York
-$662K
5
LWM
Laidlaw Wealth Management
New York
-$477K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jones Financial Companies
26
Jones Financial Companies
Missouri
$167K +$87K +3,899 +97%
PS
27
Principal Securities
Iowa
$29.8K – – –
T
28
Tidemark
California
$29.1K +$3.39K +152 +12%
Carson Wealth (CWM LLC)
29
Carson Wealth (CWM LLC)
Nebraska
$28K -$2.23K -100 -7%
SS
30
Sunbelt Securities
Texas
$20.5K -$2.23K -100 -9%
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
$16K – – –
PCFFS
32
Pacific Center for Financial Services
California
$15K -$2.77K -124 -14%
GWM
33
Geneos Wealth Management
Colorado
$6.68K +$7.28K +326 New
Comerica Bank
34
Comerica Bank
Texas
$6.17K +$6.72K +301 New
FDCDDQ
35
Federation des caisses Desjardins du Quebec
Quebec, Canada
$6.15K – – –
IA
36
IFP Advisors
Florida
$5.96K – – –
MMCM
37
Murphy & Mullick Capital Management
New York
$5.63K – – –
AIC
38
Archer Investment Corporation
Indiana
$5.08K – – –
TCM
39
TD Capital Management
Tennessee
$4.85K – – –
WIM
40
Westside Investment Management
California
$3.07K – – –
HWA
41
HHM Wealth Advisors
Tennessee
$2.77K – – –
AWM
42
AE Wealth Management
Kansas
$2.73K – – –
BBPWM
43
Blue Bell Private Wealth Management
Pennsylvania
$2.25K – – –
FFA
44
Farther Finance Advisors
California
$2.14K +$2.39K +107 New
PNC Financial Services Group
45
PNC Financial Services Group
Pennsylvania
$2.05K – – –
1NWS
46
1 North Wealth Services
Maryland
$1.74K +$1.9K +85 New
GSWM
47
Golden State Wealth Management
California
$1.59K – – –
PA
48
Parallel Advisors
California
$63 +$67 +3 New
FTUS
49
Flow Traders U.S.
New York
– -$2.13M -94,333 Closed
TW
50
Transform Wealth
Colorado
– -$721K -31,862 Closed
1
2
3

IDNA Hedge Fund Activity: Q1 2025 in Review

48 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q1 2025, worth a combined $44.4M — down 9.1% from $48.8M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of IDNA and 5 opened new positions — a net loss of 10 holders — while 11 trimmed existing stakes and 17 added.

The largest buyer was Raymond James Financial, adding an estimated $2.16M. The largest seller was Flow Traders U.S., exiting entirely with an estimated $2.13M sold.

  • 48 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q1 2025, down from 58 in Q4 2024.
  • Funds reported $44.4M of iShares Genomics Immunology and Healthcare ETF stock for Q1 2025, down 9.1% quarter-over-quarter.
  • 5 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q1 2025 and 15 closed out, a net change of -10 holders.
  • The largest iShares Genomics Immunology and Healthcare ETF buyer in Q1 2025 was Raymond James Financial, an estimated $2.16M added.
  • The largest iShares Genomics Immunology and Healthcare ETF seller in Q1 2025 was Flow Traders U.S., an estimated $2.13M sold.

Based on aggregated 13F filings for Q1 2025.